Arita, Y., S. Kihara, N. Ouchi, et al. 1999.
“Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity.” Biochemical and Biophysical Research Communications 257 (1): 79–83.
https://doi.org/10.1006/bbrc.1999.0255.
Arner, E., P. O. Westermark, K. L. Spalding, et al. 2010.
“Adipocyte turnover: relevance to human adipose tissue morphology.” Diabetes 59 (1): 105–9.
https://doi.org/10.2337/db09-0942.
Arner, P. 2005.
“Human fat cell lipolysis: biochemistry, regulation and clinical role.” Best Practice & Research. Clinical Endocrinology & Metabolism 19 (4): 471–82.
https://doi.org/10.1016/j.beem.2005.07.004.
Bujalska, I. J., S. Kumar, and P. M. Stewart. 1997.
“Does central obesity reflect "Cushing’s disease of the omentum"?” Lancet (London, England) 349 (9060): 1210–13.
https://doi.org/10.1016/S0140-6736(96)11222-8.
Cancello, R., J. Tordjman, C. Poitou, et al. 2006.
“Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity.” Diabetes 55 (6): 1554–61.
https://doi.org/10.2337/db06-0133.
Chaston, T. B., and J. B. Dixon. 2008.
“Factors associated with percent change in visceral versus subcutaneous abdominal fat during weight loss: findings from a systematic review.” International Journal of Obesity (2005) 32 (4): 619–28.
https://doi.org/10.1038/sj.ijo.0803761.
Chau, Y. Y., R. Bandiera, A. Serrels, et al. 2014.
“Visceral and subcutaneous fat have different origins and evidence supports a mesothelial source.” Nature Cell Biology 16 (4): 367–75.
https://doi.org/10.1038/ncb2922.
Cinti, S. 2005.
“The adipose organ.” Prostaglandins, Leukotrienes, and Essential Fatty Acids 73 (1): 9–15.
https://doi.org/10.1016/j.plefa.2005.04.010.
Cinti, S., G. Mitchell, G. Barbatelli, et al. 2005.
“Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans.” Journal of Lipid Research 46 (11): 2347–55.
https://doi.org/10.1194/jlr.M500294-JLR200.
Cypess, A. M., S. Lehman, G. Williams, et al. 2009.
“Identification and importance of brown adipose tissue in adult humans.” The New England Journal of Medicine 360 (15): 1509–17.
https://doi.org/10.1056/NEJMoa0810780.
Eriksson-Hogling, D., D. P. Andersson, J. Bäckdahl, et al. 2015.
“Adipose tissue morphology predicts improved insulin sensitivity following moderate or pronounced weight loss.” International Journal of Obesity (2005) 39 (6): 893–98.
https://doi.org/10.1038/ijo.2015.18.
Examination Committee of Criteria for ’Obesity Disease’ in Japan, and Japan Society for the Study of Obesity. 2002.
“New criteria for ’obesity disease’ in Japan.” Circulation Journal : Official Journal of the Japanese Circulation Society 66 (11): 987–92.
https://doi.org/10.1253/circj.66.987.
Fried, S. K., D. A. Bunkin, and A. S. Greenberg. 1998.
“Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid.” The Journal of Clinical Endocrinology and Metabolism 83 (3): 847–50.
https://doi.org/10.1210/jcem.83.3.4660.
Garg, A. 2004.
“Acquired and inherited lipodystrophies.” The New England Journal of Medicine 350 (12): 1220–34.
https://doi.org/10.1056/NEJMra025261.
Gesta, S., M. Blüher, Y. Yamamoto, et al. 2006.
“Evidence for a role of developmental genes in the origin of obesity and body fat distribution.” Proceedings of the National Academy of Sciences of the United States of America 103 (17): 6676–81.
https://doi.org/10.1073/pnas.0601752103.
Hall, K. D. 2008.
“What is the required energy deficit per unit weight loss?” International Journal of Obesity (2005) 32 (3): 573–76.
https://doi.org/10.1038/sj.ijo.0803720.
Hotamisligil, G. S., N. S. Shargill, and B. M. Spiegelman. 1993.
“Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance.” Science (New York, N.Y.) 259 (5091): 87–91.
https://doi.org/10.1126/science.7678183.
Ibrahim, M. M. 2010.
“Subcutaneous and visceral adipose tissue: structural and functional differences.” Obesity Reviews : An Official Journal of the International Association for the Study of Obesity 11 (1): 11–18.
https://doi.org/10.1111/j.1467-789X.2009.00623.x.
Kelley, D. E., F. L. Thaete, F. Troost, T. Huwe, and B. H. Goodpaster. 2000.
“Subdivisions of subcutaneous abdominal adipose tissue and insulin resistance.” American Journal of Physiology. Endocrinology and Metabolism 278 (5): E941–8.
https://doi.org/10.1152/ajpendo.2000.278.5.E941.
Knittle, J. L., K. Timmers, F. Ginsberg-Fellner, R. E. Brown, and D. P. Katz. 1979.
“The growth of adipose tissue in children and adolescents. Cross-sectional and longitudinal studies of adipose cell number and size.” The Journal of Clinical Investigation 63 (2): 239–46.
https://doi.org/10.1172/JCI109295.
Kuk, J. L., T. J. Saunders, L. E. Davidson, and R. Ross. 2009.
“Age-related changes in total and regional fat distribution.” Ageing Research Reviews 8 (4): 339–48.
https://doi.org/10.1016/j.arr.2009.06.001.
Lee, M. J., Y. Wu, and S. K. Fried. 2013.
“Adipose tissue heterogeneity: implication of depot differences in adipose tissue for obesity complications.” Molecular Aspects of Medicine 34 (1): 1–11.
https://doi.org/10.1016/j.mam.2012.10.001.
Lehmann, J. M., L. B. Moore, T. A. Smith-Oliver, W. O. Wilkison, T. M. Willson, and S. A. Kliewer. 1995.
“An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma).” The Journal of Biological Chemistry 270 (22): 12953–56.
https://doi.org/10.1074/jbc.270.22.12953.
Loke, Y. K., S. Singh, and C. D. Furberg. 2009.
“Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis.” CMAJ : Canadian Medical Association Journal = Journal de l’Association Medicale Canadienne 180 (1): 32–39.
https://doi.org/10.1503/cmaj.080486.
Lovejoy, J. C., C. M. Champagne, L. de Jonge, H. Xie, and S. R. Smith. 2008.
“Increased visceral fat and decreased energy expenditure during the menopausal transition.” International Journal of Obesity (2005) 32 (6): 949–58.
https://doi.org/10.1038/ijo.2008.25.
Manolopoulos, K. N., F. Karpe, and K. N. Frayn. 2010.
“Gluteofemoral body fat as a determinant of metabolic health.” International Journal of Obesity (2005) 34 (6): 949–59.
https://doi.org/10.1038/ijo.2009.286.
Mehlem, A., C. E. Hagberg, L. Muhl, U. Eriksson, and A. Falkevall. 2013.
“Imaging of neutral lipids by oil red O for analyzing the metabolic status in health and disease.” Nature Protocols 8 (6): 1149–54.
https://doi.org/10.1038/nprot.2013.055.
Miyazaki, Y., A. Mahankali, M. Matsuda, et al. 2002.
“Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients.” The Journal of Clinical Endocrinology and Metabolism 87 (6): 2784–91.
https://doi.org/10.1210/jcem.87.6.8567.
Nesto, R. W., D. Bell, R. O. Bonow, et al. 2003.
“Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. October 7, 2003.” Circulation 108 (23): 2941–48.
https://doi.org/10.1161/01.CIR.0000103683.99399.7E.
Nielsen, S., Z. Guo, C. M. Johnson, D. D. Hensrud, and M. D. Jensen. 2004.
“Splanchnic lipolysis in human obesity.” The Journal of Clinical Investigation 113 (11): 1582–88.
https://doi.org/10.1172/JCI21047.
Oral, E. A., V. Simha, E. Ruiz, et al. 2002.
“Leptin-replacement therapy for lipodystrophy.” The New England Journal of Medicine 346 (8): 570–78.
https://doi.org/10.1056/NEJMoa012437.
Pawlina, W., and M. H. Ross. 2020. Histology: A Text and Atlas: With Correlated Cell and Molecular Biology. 8th ed. Wolters Kluwer.
Rosen, E. D., and B. M. Spiegelman. 2014.
“What we talk about when we talk about fat.” Cell 156 (1-2): 20–44.
https://doi.org/10.1016/j.cell.2013.12.012.
Ryo, M., T. Nakamura, S. Kihara, et al. 2004.
“Adiponectin as a biomarker of the metabolic syndrome.” Circulation Journal : Official Journal of the Japanese Circulation Society 68 (11): 975–81.
https://doi.org/10.1253/circj.68.975.
Shimomura, I., T. Funahashi, M. Takahashi, et al. 1996.
“Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity.” Nature Medicine 2 (7): 800–803.
https://doi.org/10.1038/nm0796-800.
Spalding, K. L., E. Arner, P. O. Westermark, et al. 2008.
“Dynamics of fat cell turnover in humans.” Nature 453 (7196): 783–87.
https://doi.org/10.1038/nature06902.
Sun, K., C. M. Kusminski, and P. E. Scherer. 2011.
“Adipose tissue remodeling and obesity.” The Journal of Clinical Investigation 121 (6): 2094–101.
https://doi.org/10.1172/JCI45887.
Tchkonia, T., D. E. Morbeck, T. Von Zglinicki, et al. 2010.
“Fat tissue, aging, and cellular senescence.” Aging Cell 9 (5): 667–84.
https://doi.org/10.1111/j.1474-9726.2010.00608.x.
Tchkonia, T., Y. D. Tchoukalova, N. Giorgadze, et al. 2005.
“Abundance of two human preadipocyte subtypes with distinct capacities for replication, adipogenesis, and apoptosis varies among fat depots.” American Journal of Physiology. Endocrinology and Metabolism 288 (1): E267–77.
https://doi.org/10.1152/ajpendo.00265.2004.
Tchkonia, T., T. Thomou, Y. Zhu, et al. 2013.
“Mechanisms and metabolic implications of regional differences among fat depots.” Cell Metabolism 17 (5): 644–56.
https://doi.org/10.1016/j.cmet.2013.03.008.
Van Harmelen, V., S. Reynisdottir, P. Eriksson, et al. 1998.
“Leptin secretion from subcutaneous and visceral adipose tissue in women.” Diabetes 47 (6): 913–17.
https://doi.org/10.2337/diabetes.47.6.913.
Virtue, S., and A. Vidal-Puig. 2010.
“Adipose tissue expandability, lipotoxicity and the Metabolic Syndrome–an allostatic perspective.” Biochimica Et Biophysica Acta 1801 (3): 338–49.
https://doi.org/10.1016/j.bbalip.2009.12.006.
Weisberg, S. P., D. McCann, M. Desai, M. Rosenbaum, R. L. Leibel, and Ferrante AW Jr. 2003.
“Obesity is associated with macrophage accumulation in adipose tissue.” The Journal of Clinical Investigation 112 (12): 1796–808.
https://doi.org/10.1172/JCI19246.
Weyer, C., J. E. Foley, C. Bogardus, P. A. Tataranni, and R. E. Pratley. 2000.
“Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance.” Diabetologia 43 (12): 1498–506.
https://doi.org/10.1007/s001250051560.
WHO Expert Consultation. 2004.
“Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies.” Lancet (London, England) 363 (9403): 157–63.
https://doi.org/10.1016/S0140-6736(03)15268-3.
Wu, J., P. Boström, L. M. Sparks, et al. 2012.
“Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human.” Cell 150 (2): 366–76.
https://doi.org/10.1016/j.cell.2012.05.016.